AOD9604 Catalog Comparison Notes — this article examines published research context, laboratory applications, and procurement notes for AOD9604 (2mg / 5mg / 10mg) in Metabolic Research programs at Sulan Peptide Official.
AOD9604 is a synthetic peptide analog derived from the C-terminal region of human growth hormone. It is used in laboratory research on lipid-metabolism signaling, GH-fragment structure-activity relationships, and peptide pathways involved in metabolic regulation.
Sulan Peptide lists AOD9604 in the Metabolic Research category for qualified buyers reviewing GH-fragment peptide products, vial specifications, Cat No. references, and pricing before preparing a quotation request.
Available AOD9604 formats include 2mg, 5mg, and 10mg options. The product page is structured to support research-use sourcing review with molecular data, purity target, appearance, storage guidance, and quote-cart information.
Laboratories preparing AOD9604 protocols commonly pair the material with Sterile Bacteriostatic Water (BAC), Precision laboratory pipettes, Low-bind microtubes, Vial storage organizers (-20°C). These are workflow accessories—not bundled in the vial.
Research teams working with AOD9604 often include Metabolic research labs, Lipid-metabolism signaling researchers, GH-fragment peptide research teams, Preclinical peptide pharmacology groups, Qualified peptide procurement teams. These groups typically require documented peptide identity, batch COA review, and RUO compliance before releasing material into cell or animal protocols.
Research literature examines β3-adrenergic pathway cross-talk and fat-cell lipolysis markers in vitro when adipocyte lines are exposed to fragment analogs.
Glycerol release assays, adipocyte differentiation timelines, and receptor-binding competition experiments appear frequently in fragment-peptide research papers.
Early patent and academic literature positioned AOD9604 analogs as tools for dissecting GH fragment biology separate from IGF-1 mediated growth signaling.
AOD9604 corresponds to a modified fragment of the GH polypeptide C-terminal region studied for lipolytic signaling in adipocyte models without full GH receptor activation.
Catalog comparison: When evaluating AOD9604 within Metabolic Research, compare vial format (2mg / 5mg / 10mg), documented purity, and COA availability—not product names alone.
Related catalog items in the same research direction include 5-Amino-1MQ, Adipote, Cagrilintide, Mazdutide. Open parallel product tabs and export specification fields before leadership approval.
Blend kits versus single-peptide vials serve different experimental designs; confirm protocol requirements before selecting AOD9604 over alternatives.
Network meta-analyses in Metabolic Research rarely include identical AOD9604 specifications—match mg strength when citing external effect sizes.
Price-per-mg comparisons for AOD9604 should include documentation and shipping costs, not vial price alone.
Dose–response studies with AOD9604 typically span log-scale concentrations; your protocol should state whether dosing is by mass (2mg / 5mg / 10mg) or molarity derived from molecular weight on the product page.
Published Metabolic Research papers often include positive and negative assay controls alongside AOD9604; budget control compounds before ordering experimental material.
When designing multi-arm studies, randomize vial lot assignment and blind analysts to supplier identity until primary readouts are locked—this reduces bias in vendor comparison experiments involving AOD9604.
Literature searches for AOD9604 should use both trade names and CAS 221231-10-3 to capture mechanistic papers missed by supplier marketing keywords alone.
Pilot experiments with AOD9604 often start at mid-range catalog specifications (2mg / 5mg / 10mg) before scaling quantity for full study cohorts.
Cell viability panels should precede mechanism assays when introducing AOD9604 to new cell lines—unexpected toxicity may reflect solvent choice rather than peptide sequence.
Catalog specification data for AOD9604 lists CAS 221231-10-3, Molecular formula C78H123N23O23S2. molecular weight 1815.1 g/mol, and purity target ≥ 99.0%. Match these identifiers to incoming COA documents and internal sample labels before assay use.
Supplier storage guidance for AOD9604: Store at -20°C, in a cool and dry place. Log receipt date, lot number, and freezer location when material enters your inventory. Plan aliquots before reconstitution to limit freeze-thaw cycles during multi-week assay series.
Available AOD9604 research formats on sulanpeptide.shop include 2mg10vials, 5mg10vials, 10mg*10vials. Cat No. references (2AD, 5AD, 10AD) should appear on requisitions so quoted material matches the specification selected during protocol design.
Shipping seasonality can affect lyophilized cake integrity for AOD9604; inspect vials after extreme transit delays even if COA predates shipment.
Training records for staff handling AOD9604 should cover reconstitution math, RUO policy, and spill cleanup for research laboratories.
For long-horizon Metabolic Research projects, document freezer location and thaw count on every aliquot label tied to AOD9604 lot numbers.
Appearance notes (White Lyophilized Powder) help detect moisture exposure or handling damage during receiving inspection of AOD9604.
Internal IRB or IACUC protocols should cite RUO scope explicitly when AOD9604 appears in animal or human-derived tissue research models.
Compare published assay incubation times for AOD9604; overnight versus short pulses can invert apparent potency rankings in receptor assays.
Purity target ≥ 99.0% on the catalog is a specification goal—your QA team should confirm the specific lot COA meets internal thresholds before release.
When AOD9604 appears in combination with other peptides, cite each sequence’s Cat No. in publications to satisfy reproducibility standards in Metabolic Research journals.
Statistical plans should pre-register primary endpoints before unblinding AOD9604 treatment arms in preclinical models.
AOD9604 from Sulan Peptide Official is supplied for research use only (RUO)—not for human or veterinary use, diagnosis, or treatment. Direct specification or quotation questions via the Contact page or WhatsApp on sulanpeptide.shop.